Darrin M. Beaupre, M.D., Ph.D.

Darrin M. Beaupre, M.D., Ph.D.

Chief Medical OfficeratIDEAYA Biosciences· In proxies 2022–2025

Pay in FY2025-45% from the year before · IDEAYA Biosciences stock +34.5% the same year

Darrin M. Beaupre, M.D., Ph.D. was paid $3.3M in FY2025 (Dec), down 45%. IDEAYA Biosciences stock rose 34.5% that year.

Pay$100 in the stock at the end of FY21 → $146
Pay is from the Summary Compensation Table of each IDEAYA Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. IDEAYA BiosciencesPublic company · 4 yr
    • Chief Medical Officer2022 – Present · 4 yrStock in role +46%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?